This guiding document represents both the Journal's primary approach to Clinical Decision Science and its instructions to authors wishing to write and submit a Clinical Decision Report.
- Who Can Submit?
- Manuscript Submission Guidelines
- Peer Review
- Formatting Requirements
- Rights for Authors and DigitalCommons@WayneState
Who Can Submit?
Submissions are accepted generally. Submission pre-assumes that the submitter owns the copyright to the work being submitted or is authorized by the copyright owner or owners to submit the article. There are no charges required to submit, nor are there any fees should a submission be accepted.
Manuscript Submission Guidelines
Submitted articles cannot have been previously published, nor be forthcoming in an archival journal or book (print or electronic). Please note: "publication" in a working-paper series does not constitute prior publication. In addition, by submitting material to Clinical Research in Practice: The Journal of Team Hippocrates, the author is stipulating that the material is not currently under review at another journal (electronic or print) and that he or she will not submit the material to another journal (electronic or print) until the completion of the editorial decision process at Clinical Research in Practice: The Journal of Team Hippocrates. If you have concerns about the submission terms for Clinical Research in Practice: The Journal of Team Hippocrates, please contact the editors.
All editorial decisions are final. Editors reserve the right to copyedit accepted submissions.
Clinical Research in Practice: The Journal of Team Hippocrates is designed to further our understanding of education, clinical research and clinical practice. Physicians learn the art and science of medicine through role modelling, experiential learning, reflection and original investigation. These learning techniques are mirrored in the types of submissions the journal accepts. These include the following categories:
These manuscripts follow a different format than typical research papers. The intent is to replicate the clinical process of care. The section headings should include: Clinical Context, Clinical Question, Research Article Citation, Description of Related Literature, Critical Appraisal, Clinical Application, New Knowledge Related to Clinical Decision Science, Conflict of Interest Statement, and References.
Detailed instructions can be found at the following link: Guidelines for Writing and Reviewing a Clinical Decision Report. These instructions are mandatory for all Clinical Decision Report submissions.
Clinical Decision Reports are guided by Wayne State University's policies concerning review of research by WSU's Institutional Review Board (IRB), and determinations regarding Human Participant Research (HPR). Per the IRB, "the regulatory requirement for IRB review, under the Common Rule applies to research that is “a systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge.” Only research meeting this definition (definition of Human Participant Research or HPR) or research for which the FDA regulations apply requires IRB review and IRB oversight." The policies specifically dismiss reports "which describe an interesting treatment, presentation, or outcome," and which follow certain guidelines around protected health information elements under HIPPA. This specific policy is detailed generally at https://research.wayne.edu/irb/forms-requirements-categories, and more specifically at https://research.wayne.edu/irb/docs/hpr_guidance-_activities_that_are_not_hpr_4_10_19.pdf.
Guidelines for Brief Reports and Original Research
Clinical Research in Practice: The Journal of Team Hippocrates is interested in manuscripts that respond to the Aims and Scope of the journal. We are particularly interested in papers that inform our readers about how evidence is actually used, misused, or not used in clinical practice. We hope to expand our understanding of current clinical practice and discover methods to facilitate changes responsive to the Translational Medicine paradigm from the NIH. The practice of medicine is rapidly evolving and we aim to preserve and enhance the scientific basis of clinical practice.
All submissions to Clinical Research in Practice: The Journal of Team Hippocrates should be composed in Microsoft Word in a manner consistent with the uniform instructions for authors as published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: www.icmje.org. This includes ICMJE qualifications for authorship. Quantitative and qualitative work is encouraged.
Brief reports are appropriate for pilot studies or data collected for conference abstracts. The word limit is 1000 words, not including the title page, abstract, or references.
Original research manuscripts are for completed research protocols. The word limit is 2000 words, not including the title page, abstract, or references.
Brief Reports and Original Research manuscript submissions should include:
- Title page with
- authors’ names, titles, and institutions
- contact information for corresponding author
- financial support
- prior presentations of manuscript content
- conflicts of interest
- Abstract using the headings Introduction, Methods, Results, Discussion. Abstract word limit is 250 words.
- Introduction: Summarize current knowledge, supported by references. Describe why this contextual information helped formulate the project. A clear statement of research goal or hypothesis should be stated explicitly.
- Methods: Describe the methods of the research in sufficient detail to allow replication of the study. This section must include a statement regarding IRB approval or exemption status. Guidelines for Clinical Decision Report manuscripts can serve as a template for a well written research manuscript.
- Results: Results of the study should be presented in a complete, but succinct manner. Measures of precision and statistical adequacy should be included. A limit of five tables and figures are allowed and should be uploaded through the supplemental material section of the manuscript submission page.
- Discussion: This section should describe how the results of the study relate to the research question or hypothesis described in the introduction. The section must also include a statement of how the research pertains to the Aims and Scope of the journal.
- References: Please use AMA Manual of Style
Guidelines for Informed Consent Manuscripts
These manuscripts summarize a body of clinical research and explain it in language a patient can understand.
Detailed instructions can be found at the following link: Guidelines for Writing and Reviewing an "Informed Consent Manuscript". These instructions are mandatory for all Informed Consent submissions.
Guidelines for Reflections on Clinical Decision-Making
The intent of this journal is to explore, learn, and practice how to use clinical research while caring for patients. The editors believe that personal reflections about experiences that illuminate the importance of the social context of the patient to the application of clinical research literature are stories worth sharing. These reflections should describe actual real-life clinical situations. Of particular interest are reflections that spark important new questions related to Clinical Decision Science as described in the Aims and Scope of our journal. This type of submission is the place to ask important questions, which in turn become the topics of inquiry for future scholarship. (500 words)
Guidelines for Letters to the Editor
This category is for short comments that will add to the conversation about issues discussed in this journal. This includes comments about regular articles or comments related to the overall intent of the journal. (250 words)
Peer Review Procedures
Submissions to Clinical Decision Reports, Brief Reports, and Original Research undergo double blind review by at minimum two peers. Submissions to Reflections on Clinical Decision Science, Informed Consent, and Letters to the Editor generally undergo editorial review.
- Submit manuscripts using the Submit Article link in the sidebar.
- Complete the Conflict of Interest Disclosure Statement while submitting; include it as supplemental material in the submission.
- Please double space the manuscript.
- Use 1 inch margins.
- Indent the first sentence of each paragraph.
- Use only generic names for pharmaceuticals.
- Word count limit for regular article manuscripts is 1500 words. Reflections word count limit is 500 words, and Letters to the Editor is limited to 250 words.
Rights for Authors and Clinical Research in Practice: The Journal of Team Hippocrates
Authors retain all copyright to articles published in Clinical Research in Practice: The Journal of Team Hippocrates, but grant a universal limited license to the copyrights in the article as described under the Creative Commons Attribution 4.0 International (CC-BY 4.0) License, requiring credit to the author and Clinical Research in Practice: The Journal of Team Hippocrates as the copyright holder and original publisher, respectively, for any post-publication reuse of the material.
Authors and other stakeholders are encouraged to link to material published in the journal, and to deposit or archive the article as part of a non-commercial open access institutional repository or other non-commercial open access publication site affiliated with the author(s)'s scholarly institution of record, under the terms of the CC-BY 4.0 license.
General Terms and Conditions of Use
Users of the DigitalCommons@WayneState website and/or software agree not to misuse the DigitalCommons@WayneState service or software in any way.
The failure of DigitalCommons@WayneState to exercise or enforce any right or provision in the policies or the Submission Agreement does not constitute a waiver of such right or provision. If any term of the Submission Agreement or these policies is found to be invalid, the parties nevertheless agree that the court should endeavor to give effect to the parties' intentions as reflected in the provision, and the other provisions of the Submission Agreement and these policies remain in full force and effect. These policies and the Submission Agreement constitute the entire agreement between DigitalCommons@WayneState and the Author(s) regarding submission of the Article.